🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06196931
Starting soon Observational

Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease

NCT06196931 · tracked via the Priya Life Science China tracker
Sponsor
Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine
Phase
Observational
Started
2024-01-01
Last updated
2024-01-09

Condition(s) studied

Hepatolenticular Degeneration; Wilson

Study summary

In earlier studies, it was found that patients of Wilson disease with new diagnosed who only has neurological symptoms often had DWI hyper-intensity in brain MRI, which was more common in putamen and midbrain, indicating that the disease was in the acute stage. However, many patients had ADC hyper-intensity or hypo-intensity at the same time, and the two different signals represented different disease processes from an imaging perspective. The former indicating T2 penetration effect, and the latter represents diffusion limitation, which indicating the presence of local inflammation, edema, etc. Whether the signal changes of these two different matching modes have guiding significance for the early de-copper treatment for WD, one is the core point of our study. We hope to exploring the predictive value about DWI-ACD signal matching for symptoms changes in the earlier time of de-copper treatment through this study.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients had been previously diagnosed with WD who both had DWI hyper-intensity and ADC hyper-intensity or hypo-intensity at the same time; 2. Patients who accept de-copper treatment in hospitalization for 4 weeks or more. Exclusion Criteria: 1. Patients who only with liver injury; 2. Severe complications; 3. Combined with other diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The affiliated hospital of Institute of Neurology in Anhui University of Chinese Medicine Hefei Anhui
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06196931 on ClinicalTrials.gov ↗ ← All trials in China